Investor Relations Department Pty Ltd
  • About Us
  • What We Do
    • What We Do
    • Investor Relations
    • IPO Readiness
    • Media Relations
    • Issues and Crisis Communications
    • Digital Content & Social Media Activation
    • Marketing and Brand Campaigns
    • Video Production
  • Team
    • Our Senior Team
  • News & Insights
    • Newsletters
    • Blog
  • IRD Invest
    • Project: 2025
    • Addressing the need for change 2021
    • Technology 2020
    • Biotech 2020
  • Careers
    • Seeking a media gun to join our team
  • Contact Us
    • Contact Us
    • Email Alerts
IR Department Newsletter - March 2022
News & Insights >
  • Newsletters
  • Blog

Recent Posts

  • IRD Invest March 2022 - Openpay
  • IRD Invest March 2022 - Oventus
  • IRD Invest March 2022 - Pureprofile
  • Register now for our next IRD Invest virtual investor conference, where emerging tech companies will talk about the tailwinds driving their businesses
  • CEO in focus - Pureprofile's Martin Filz

Archives

  • March 2022
  • February 2022
  • December 2021
  • October 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • March 2021
  • December 2020
  • October 2020
  • September 2020
  • August 2020
  • April 2020
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019

Categories

  • AGMs
  • Crisis communications
  • Investor relations
  • Newsletter March 2022
  • Uncategorized

Introduction to Newsletter March 2022

IRDInvest3
March 25th, 2022

Register now for our next IRD Invest virtual investor conference, where emerging tech companies will talk about the tailwinds driving their businesses

Read More
Martinbw
March 24th, 2022

CEO in focus - Pureprofile's Martin Filz

Read More
PeterJohn3
March 24th, 2022

UniSeed: UniSuper makes first venture capital foray with $75m funding (afr.com)

Read More
AdobeStock_164771711
March 24th, 2022

Servatus launches new trial into the effects of live biotherapeutics on insomnia

Read More
AdobeStock_261939312
March 23rd, 2022

Kazia begins phase II study into paxalisib + a keto diet to treat brain cancer

Read More
IRD logo square
March 23rd, 2022

Recent client coverage highlights

Read More
NEW MattHeadShot
March 17th, 2022

XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference

Read More
ProactiveattheASXSmallandMidCapConference
March 16th, 2022

Race Oncology speaks to Proactive Investor as part of the ASX Small and Mid-Cap Conference

Read More
image001
March 11th, 2022

Proactive does a deep dive into AdAlta via "Combatting fibrosis"

Read More
internationalwomensday800x350
March 8th, 2022

IR Department celebrates International Women's Day 2022

Read More
shutterstock_731491177
February 16th, 2022

Learn more about HaemaLogix’s ground-breaking KappaMab technology

Read More
  • 1


Quick Links

Contact Us

Suite 67, Level 14, 88 Pitt St
Sydney, NSW 2000
Tel: +61 411 117 774

Receive our News

Which of the following group do you best fit?

 

Email Alerts

Subscribe to our Email Alerts

Follow Us

Copyright © Investor Relations Department Pty Ltd
Site Map Privacy Search
Site by